TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

1 Parkinson's Disease (PD) Drugs Market Overview
1.1 Product Overview and Scope of Parkinson's Disease (PD) Drugs
1.2 Parkinson's Disease (PD) Drugs Segment by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Parkinson's Disease (PD) Drugs Segment by Application
1.3.1 Global Parkinson's Disease (PD) Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Hospital
1.3.3 Family
1.4 Global Parkinson's Disease (PD) Drugs Market Size Estimates and Forecasts
1.4.1 Global Parkinson's Disease (PD) Drugs Revenue 2017-2030
1.4.2 Global Parkinson's Disease (PD) Drugs Sales 2017-2030
1.4.3 Parkinson's Disease (PD) Drugs Market Size by Region: 2017 Versus 2022 Versus 2030
2 Parkinson's Disease (PD) Drugs Market Competition by Manufacturers
2.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2017-2023)
2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2017-2023)
2.4 Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
2.5.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
2.5.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parkinson's Disease (PD) Drugs Retrospective Market Scenario by Region
3.1 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Sales by Region: 2017-2023
3.2 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Revenue by Region: 2017-2023
3.3 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.3.1 North America Parkinson's Disease (PD) Drugs Sales by Country
3.3.2 North America Parkinson's Disease (PD) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.4.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
3.4.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
3.5.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.6.1 Latin America Parkinson's Disease (PD) Drugs Sales by Country
3.6.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country
3.7.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Parkinson's Disease (PD) Drugs Historic Market Analysis by Type
4.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2023)
4.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2023)
4.3 Global Parkinson's Disease (PD) Drugs Price by Type (2017-2023)
5 Global Parkinson's Disease (PD) Drugs Historic Market Analysis by Application
5.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2023)
5.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2023)
5.3 Global Parkinson's Disease (PD) Drugs Price by Application (2017-2023)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Novartis Parkinson's Disease (PD) Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Corporation Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.5.4 AbbVie Parkinson's Disease (PD) Drugs Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Abital Pharma
6.6.1 Abital Pharma Corporation Information
6.6.2 Abital Pharma Description and Business Overview
6.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Product Portfolio
6.6.5 Abital Pharma Recent Developments/Updates
6.7 Addex Therapeutics
6.6.1 Addex Therapeutics Corporation Information
6.6.2 Addex Therapeutics Description and Business Overview
6.6.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Portfolio
6.7.5 Addex Therapeutics Recent Developments/Updates
6.8 Biogen
6.8.1 Biogen Corporation Information
6.8.2 Biogen Description and Business Overview
6.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Biogen Parkinson's Disease (PD) Drugs Product Portfolio
6.8.5 Biogen Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Eisai Parkinson's Disease (PD) Drugs Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Corporation Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 F. Hoffmann-La Roche
6.11.1 F. Hoffmann-La Roche Corporation Information
6.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Description and Business Overview
6.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Portfolio
6.11.5 F. Hoffmann-La Roche Recent Developments/Updates
6.12 H. Lundbeck
6.12.1 H. Lundbeck Corporation Information
6.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Description and Business Overview
6.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Product Portfolio
6.12.5 H. Lundbeck Recent Developments/Updates
6.13 Impax Laboratories
6.13.1 Impax Laboratories Corporation Information
6.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Description and Business Overview
6.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Product Portfolio
6.13.5 Impax Laboratories Recent Developments/Updates
6.14 Kyowa Hakko Kirin
6.14.1 Kyowa Hakko Kirin Corporation Information
6.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Description and Business Overview
6.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Portfolio
6.14.5 Kyowa Hakko Kirin Recent Developments/Updates
6.15 Otsuka Pharmaceutical
6.15.1 Otsuka Pharmaceutical Corporation Information
6.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Description and Business Overview
6.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Portfolio
6.15.5 Otsuka Pharmaceutical Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Parkinson's Disease (PD) Drugs Description and Business Overview
6.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2023)
6.16.4 Pfizer Parkinson's Disease (PD) Drugs Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
7 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis
7.1 Parkinson's Disease (PD) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
7.4 Parkinson's Disease (PD) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parkinson's Disease (PD) Drugs Distributors List
8.3 Parkinson's Disease (PD) Drugs Customers
9 Parkinson's Disease (PD) Drugs Market Dynamics
9.1 Parkinson's Disease (PD) Drugs Industry Trends
9.2 Parkinson's Disease (PD) Drugs Market Drivers
9.3 Parkinson's Disease (PD) Drugs Market Challenges
9.4 Parkinson's Disease (PD) Drugs Market Restraints
10 Global Market Forecast
10.1 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Type (2023-2030)
10.2 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Application (2023-2030)
10.3 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer